Syngene is incorporated by Mrs.Kiran Mazumdar Shaw in 1993 and become India’s largest contract research organization, which supports R;D programs from lead generation to clinical supplies. Syngene offers multi-disciplinary skills in integrated drug discovery and development include capabilities in medicinal chemistry, biology, in vivo pharmacology, toxicology, custom synthesis, process R;D, cGMP manufacturing, formulation and analytical development along with Clinical development services.
Syngene has state-of-the-art research facilities certified with ISO 9001:2008, ISO 14001:2004, and OHSAS 18001:2007. Animal facilities are GLP certified by the Indian authorities and AAALAC accredited. Over the last 20 years, Syngene successfully offered these services to more than 290 clients including start-up companies, large pharma/ biotech, agrochemical, chemical, nutrition and animal health companies in the USA, Europe and Asia Pacific including Japan. Syngene has a strong corporate governance framework with a focus on client satisfaction, quality, safety, ethics and integrity.
Over the last two decades, Syngene, through a comprehensive strategy of strengthening research capabilities and focusing on client satisfaction by implementing the digital awareness, has become a reliable and trustworthy partner for global innovator companies by continually expanding its service offerings to meet their evolving R;D needs. The Informatics capabilities strengthen the core competencies of the business towards the goal